Regeneron Pharmaceuticals

REGN Health Care Market cap $81.7B as of Sep 14, 2026 16:00 ET S&P 500

Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 30, 2026

Revenue$4.29B +17% year over year

Gross profit$3.59B 84% margin

Operating profit$1.29B 30% margin

Net profit$1.30B 30% margin

Net profit is larger than what operations earned, because the statement adds $0.23B below it, under Other income, net.

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	4.29	100%	+17%
Collaboration	2.46	57%	+32%
Product	1.64	38%	+1%
Service other	0.19	5%	+5%
Cost of revenue	−0.70	16%
Gross profit	3.59	84% margin	−2pp
R&D	−1.63	38%	−1pp
SG&A	−0.66	15%	−2pp
Operating profit	1.29	30% margin	+1pp
Other income, net	0.23
Tax	−0.23
Net profit	1.30	30% margin	−8pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	3.61	100%	+19%
Collaboration	1.90	53%	+24%
Product	1.54	42%	+8%
Service other	0.17	5%	+109%
Cost of revenue	−0.77	21%
Gross profit	2.83	79% margin	−6pp
R&D	−1.54	43%	−1pp
SG&A	−0.65	18%	−3pp
Operating profit	0.64	18% margin	−2pp
Other income, net	0.19
Tax	−0.10
Net profit	0.73	20% margin	−7pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Dec 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.88	100%	+3%
Collaboration	1.97	51%	+23%
Product	1.68	43%	−16%
Service other	0.24	6%	+33%
Cost of revenue	−0.60	16%
Gross profit	3.28	84% margin	+0pp
R&D	−1.63	42%	+5pp
SG&A	−0.78	20%	−1pp
Operating profit	0.88	23% margin	−3pp
Other income, net	0.16
Tax	−0.20
Net profit	0.85	22% margin	−2pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.75	100%	+1%
Collaboration	1.97	53%	+19%
Product	1.59	42%	−18%
Service other	0.20	5%	+74%
Other products	<0.01	0%
Cost of revenue	−0.60	16%
Gross profit	3.16	84% margin	−1pp
R&D	−1.48	39%	+5pp
SG&A	−0.66	18%	−2pp
Operating profit	1.03	27% margin	−4pp
Other income, net	0.74
Tax	−0.30
Net profit	1.46	39% margin	+3pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	3.68	100%	+4%
Collaboration	1.86	51%	+22%
Product	1.63	44%	−15%
Service other	0.18	5%	+76%
Cost of revenue	−0.54	15%
Gross profit	3.14	85% margin	+0pp
R&D	−1.42	39%	+5pp
SG&A	−0.63	17%	−4pp
Operating profit	1.08	29% margin	−1pp
Other income, net	0.44
Tax	−0.13
Net profit	1.39	38% margin	−3pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 30, 2026 Operating margin 30% Net profit $1.3B	Apr 1 – Jun 30, 2026	Jul 30, 2026	$4.3B	+17%	30%	$1.3B	30%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 29, 2026 Operating margin 18% Net profit $0.7B	Jan 1 – Mar 31, 2026	Apr 29, 2026	$3.6B	+19%	18%	$0.7B	20%
Q4 FY25 Oct 1 – Dec 31, 2025 reported Feb 4, 2026 Operating margin 23% Net profit $0.8B	Oct 1 – Dec 31, 2025	Feb 4, 2026	$3.9B	+3%	23%	$0.8B	22%
Q3 FY25 Jul 1 – Sep 30, 2025 reported Oct 28, 2025 Operating margin 27% Net profit $1.5B	Jul 1 – Sep 30, 2025	Oct 28, 2025	$3.8B	+1%	27%	$1.5B	39%
Q2 FY25 Apr 1 – Jun 30, 2025 reported Aug 1, 2025 Operating margin 29% Net profit $1.4B	Apr 1 – Jun 30, 2025	Aug 1, 2025	$3.7B	+4%	29%	$1.4B	38%